You must enable cookies for this web site to function properly.
Ask Congress to Increase Support for Lymphoma Research
We apologize, but the action alert you are attempting to access is no longer active.
Consider taking action on other issues.
Ask Your Senators to Support the Clinical Treatment Act | |
The Lymphoma Research Foundation is participating in a day of action in support of the Clinical Treatment Act, a bill which would guarantee coverage of the costs of clinical trial participation for Medicaid enrollees with a life-threatening condition. | |
Protect Immune Compromised Community Against COVID-19 | |
One January 18, LRF sent a letter to President Biden and federal health policy and scientific leadership to urge additional actions to protect immune compromised individuals against the risks of COVID-19, including people with lymphoma and CLL. | |
Ask Congress to Support Cancer Care Planning and Communications Act During BCAM | |
The Cancer Care Planning and Communications Act (H.R.3835) would encourage the development of a personalized cancer care plan for Medicare beneficiaries and ensure Medicare coverage of cancer care planning and coordination services. | |
Urge Your Legislators to Support the Cancer Drug Parity Act | |
The Cancer Drug Parity Act (H.R.1730/S.741) would ensure oral cancer drugs are covered in the same way as traditional IV chemotherapy, bringing down costs for cancer patients and eliminating financial barriers between them and lifesaving treatments. | |
Medicare Diagnostic Radiopharmaceutical Payment Equity Act | |
The bipartisan Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (HR 3772) would expand patient access to highly targeted, precision diagnostic radiopharmaceuticals allowing patients to get the right treatment faster. | |
Urge Your Legislators to Support the Cancer Drug Parity Act During BCAM | |
The Cancer Drug Parity Act (H.R.1730/S.741) would ensure oral cancer drugs are covered in the same way as traditional IV chemotherapy, bringing down costs for cancer patients and eliminating financial barriers between them and lifesaving treatments. | |
